Cardica Signs New Deal With Intuitive

August 18, 2010 · Filed Under Cardiac · Comment 

Cardica Inc. (NASDAQ: CRDC), was up $0.45 (27.11%) this afternoon to $2.11 per share.  This move is the result of a new, $12 million deal signed between Cardica and Intuitive Surgical Inc. (NASDAQ: ISRG).  As a result of the deal, Intuitive has exclusive rights to Cardica’s intellectual property pertaining to robotic surgery.

Cardica Inc. is a medical instruments company that makes surgical devices for cardiac, among other, procedures.

-Michael B. Sauter

BioHealth Earnings Floodgates Opening (BSX, BIIB, GILD, ISRG, PFE, DGX, SYK, AMGN, ELN, LLY, GENZ, STJ, BMY, MRK, SGP, ZMH)

October 16, 2009 · Filed Under Financial, General · Comments Off 

Next week is going to be the mother of all earnings reports for the BioHealth community.  We have included the key device companies as well in this calendar with the routine top drug and biotech companies.  As a reminder, these estimates may change between now and when some of the players report earnings.  In the screens for earnings we have the estimates included listed as the Thomson Reuters consensus figures.


  • Boston Scientific Corporation (NYSE: BSX) $0.14 EPS on $2.04 billion in revenues


  • Biogen Idec Inc. (NASDAQ: BIIB) $1.04 EPS on $1.11 billion in revenues
  • Gilead Sciences    Inc. (NASDAQ: GILD) $0.67 EPS on $1.76 billion in revenues
  • Intuitive Surgical, Inc. (NASDAQ: ISRG) $1.46 EPS and $256.44 million in revenues
  • Pfizer Inc. (NYSE: PFE) $0.48 EPS and $11.4 billion in revenues
  • Quest Diagnostics Inc. (NYSE: DGX) $0.96 EPS and $1.89 billion in revenues
  • Stryker Corp. (NYSE: SYK) $0.69 EPS and $$1.62 billion in revenues


  • Amgen Inc. (NASDAQ: AMGN) $1.27 EPS and $3.79 billion in revenues
  • Elan Corporation, plc (NYSE: ELN) -$0.13 EPS on $285.18 million in revenues
  • Eli Lilly & Co. (NYSE: LLY) $1.01 EPS and $5.4 billion in revenues
  • Genzyme Corporation (NASDAQ: GENZ) $0.44 EPS and $1.11 billion in revenues
  • St. Jude Medical, Inc. (NYSE: STJ) $0.58 EPS and $1.16 billion in revenues


  • Bristol-Myers Squibb (NYSE: BMY) $0.51 EPS and $5.5 billion in revenues
  • Merck & Co., Inc. (NYSE: MRK) $0.83 EPS and $6 billion in revenues
  • Schering-Plough    Corporation (NYSE: SGP) $0.39 EPS and $4.45 billion in revenues
  • Zimmer Holdings Inc. (NYSE: ZMH) $0.86 EPS and $953.6 million in revenues

OCTOBER 16, 2009

Intuitive Surgical Defended on Weakness Ahead of Presentation (ISRG)

June 11, 2008 · Filed Under General · Comments Off 

Intuitive Surgical, Inc. (NASDAQ: ISRG) has been defended after recent weakness by an analyst call as the robotic daVinci surgical system maker was started as Outperform at William Blair.

Intuitive Surgical has seen its stock under fire because of its massive valuations and its stock performance through late 2007.  Unfortunately when companies make a 20-fold run in a matter of a few years things have to change at some point.  Its shares have fallen from a peak of $350.59 to around $270.00 of late.  In short, they have lost one-quarter of their value.  Its market cap is still over $10 Billion and its forward estimated P/E ratio for 2008 is north of 50.0 in an uncertain environment.  The company is also presenting at a Needham & Co. conference today at 2 PM EST.

Shares have not traded that much in pre-market trading, but indications are up around $273.00 after a $270.27 close yesterday.

Jon Ogg
June 11, 2008

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed